New-Blurbs

Analysts Offer Insights on Financial Companies: Trupanion (TRUP) and FTAC Olympus Acquisition (FTOC)

Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Trupanion (TRUP) and FTAC Olympus Acquisition …

Canaccord Genuity Initiates a Buy Rating on Vizsla Resources (VIZSF)

Canaccord Genuity analyst Michael Pettingell initiated coverage with a Buy rating on Vizsla Resources (VIZSF) today and set a price target of C$4.00.

Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Motus Gi Holdings (MOTS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on MacroGenics (MGNX), Motus Gi Holdings …

CloudMD Software & Services (DOCRF) Receives a Buy from Canaccord Genuity

In a report released yesterday, Doug Taylor from Canaccord Genuity maintained a Buy rating on CloudMD Software & Services (DOCRF), with a price …

Analysts’ Top Healthcare Picks: AVEO Pharma (AVEO), NeuBase Therapeutics (NBSE)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on AVEO Pharma (AVEO), NeuBase Therapeutics …

H.C. Wainwright Maintains Their Hold Rating on Aprea Therapeutics (APRE)

In a report released today, Andrew Fein from H.C.

Analysts Conflicted on These Healthcare Names: Biogen (BIIB) and Beyondspring (BYSI)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Biogen (BIIB) and Beyondspring (BYSI). Biogen (BIIB) In …

Canaccord Genuity Thinks Laird Superfood’s Stock is Going to Recover

Canaccord Genuity analyst Robert Burleson maintained a Buy rating on Laird Superfood (LSF) yesterday and set a price target of $70.00.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts